Andreas Pahl
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Toxin Mechanisms and Immunotoxins
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
Papers in
- Immunology 38
- Toxin Mechanisms and Immunotoxins 23
- Pharmacology 21
- Inflammatory mediators and NSAID effects 13
- Co-authors
- Kay BruneBurkhard HinzTorsten HechlerMartin RöllinghoffMartin F. FrommChristian LutzHanns Ulrich ZeilhoferHolger Bang
- Journals
- Cancer Research (13 papers)Biochemical and Biophysical Research Communications (6 papers)Blood (6 papers)Inflammation Research (3 papers)Planta Medica (3 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Andreas Pahl
102 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Immunology 850
- Pharmacology 641
- Pharmacology 244
- Biochemistry 170
- Oncology 591
Countries citing papers authored by Andreas Pahl
This map shows the geographic impact of Andreas Pahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Pahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Pahl more than expected).
Fields of papers citing papers by Andreas Pahl
This network shows the impact of papers produced by Andreas Pahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Pahl. The network helps show where Andreas Pahl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andreas Pahl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2021 | 11 | |
| 3 | 2021 | 3 | |
| 4 | 2020 | 61 | |
| 5 | 2020 | 37 | |
| 6 | 2017 | 11 | |
| 7 | 2012 | 12 | |
| 8 | 2009 | 116 | |
| 9 | 2008 | 1 | |
| 10 | Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents Hit paper breakdown → | 2008 | 425 |
| 11 | 2007 | 14 | |
| 12 | 2007 | 1 | |
| 13 | 2006 | 58 | |
| 14 | 2004 | 54 | |
| 15 | 2001 | 31 | |
| 16 | 2001 | 40 | |
| 17 | 2000 | 71 | |
| 18 | 2000 | 37 | |
| 19 | 2000 | 248 | |
| 20 | 1998 | 36 |
About Andreas Pahl
Andreas Pahl is a scholar working on Immunology, Pharmacology, Pharmacology, Physiology and Biochemistry, having authored 105 papers that have together received 3.5k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (23 papers), Silymarin and Mushroom Poisoning (14 papers), Inflammatory mediators and NSAID effects (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Signaling Pathways in Disease (11 papers), Asthma and respiratory diseases (11 papers), Glycosylation and Glycoproteins Research (10 papers) and Neuropeptides and Animal Physiology (8 papers). The work is most often cited by research in Immunology (850 citations), Pharmacology (641 citations), Pharmacology (244 citations), Biochemistry (170 citations) and Oncology (591 citations). Andreas Pahl has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Kay Brune, Burkhard Hinz, Torsten Hechler, Martin Röllinghoff, Martin F. Fromm, Christian Lutz, Hanns Ulrich Zeilhofer, Holger Bang, Dietmar Trenk and Christian Stratz. Their work appears in journals such as Cancer Research, Biochemical and Biophysical Research Communications, Blood, Inflammation Research and Planta Medica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.